{"product_id":"chk1-antibody-sc-f0495","title":"Phospho-Chk1 (Ser317) Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eCheckpoint kinase 1 (Chk1) was originally identified as a crucial component of the DNA damage response (DDR). Beyond its role in DDR, Chk1 also plays an important part in checkpoint activation during DDR and in the regulation of the normal cell cycle. Its activation is initiated through phosphorylation at conserved sites, resulting in the phosphorylation of various substrate proteins. Depending on the literature source, CHK1 may also be discussed as Phospho-Chk1 (Ser317).\u003c\/p\u003e\u003cp\u003eReported cellular context includes chromosome, cytoplasm, cytoskeleton, and nucleus, which can matter when signal is compared across treatments or changing cell states. Following CHK1 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eCHK1 is commonly interpreted in the context of dna damage \/ repair, cell cycle, and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans chromosome, cytoplasm, and cytoskeleton, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between chromosome, cytoplasm, and cytoskeleton across matched conditions\u003c\/li\u003e\n\u003cli\u003estress-induced changes after checkpoint activation or genotoxic challenge\u003c\/li\u003e\n\u003cli\u003ecell-cycle linked differences in abundance, timing, or compartmental enrichment\u003c\/li\u003e\n\u003cli\u003esignal-dependent shifts after ligand, inhibitor, or growth-factor perturbation\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for CHK1. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in CHK1 reflect biology rather than handling. When interpreting CHK1, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep CHK1 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57577464758617,"sku":"F0495-20UL","price":169.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57577464791385,"sku":"F0495-100UL","price":419.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57577464824153,"sku":"F0495-2X100UL","price":629.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F0495-IF.png?v=1773598540","url":"https:\/\/absource-diagnostics.myshopify.com\/products\/chk1-antibody-sc-f0495","provider":"Absource Diagnostics","version":"1.0","type":"link"}